Scarica l'app Stockscreener
78.06
2.91%
2.295
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
PTC Therapeutics (NASDAQ:PTCT) Shares Down 5.6%Time to Sell? - MarketBeat
Transcript : PTC Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 10 - MarketScreener
Why PTC Therapeutics Inc. stock could rally in 2025Weekly Trend Summary & Low Risk Entry Point Guides - Newser
Can PTC Therapeutics Inc. (BH3) stock sustain breakout momentum2025 Top Gainers & Fast Entry Momentum Alerts - Newser
Will PTC Therapeutics Inc. (BH3) stock outperform global peersJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Panagora Asset Management Inc. Lowers Stock Holdings in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? - Yahoo Finance
PTC Therapeutics Investors Focus on Sephience Uptake, Huntington's Updates, RBC Says - MarketScreener
Prudential Financial Inc. Has $4.12 Million Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics stock price target raised to $55 from $50 at Goldman Sachs - Investing.com UK
Legal & General Group Plc Grows Stock Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Rare-Disease Biotech PTC Is Surging — And One Fund Just Raised Its Bet. Should You? - AOL.com
Transcript : PTC Therapeutics, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 08 - MarketScreener
Can PTC Therapeutics Inc. (BH3) stock retain market dominance2025 Support & Resistance & Low Risk High Reward Trade Ideas - Newser
How PTC Therapeutics Inc. (BH3) stock moves on employment dataQuarterly Earnings Report & Long-Term Capital Growth Strategies - Newser
Is PTC Therapeutics Inc. stock a buy for dividend growth2025 Trading Recap & Reliable Volume Spike Trade Alerts - Newser
Why PTC Therapeutics Inc stock could rally in 2025Weekly Earnings Recap & Fast Gain Swing Trade Alerts - BỘ NỘI VỤ
Will PTC Therapeutics Inc. (BH3) stock deliver stable dividendsPortfolio Value Summary & Accurate Intraday Trade Tips - Newser
This Fund Sold $30 Million in PTC Therapeutics Shares Amid a 93% Rally: Here’s Why - AOL.com
Cadrenal Therapeutics appoints PTC Therapeutics CMO to board By Investing.com - Investing.com Australia
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Barchart.com
PTC Therapeutics downgraded at RBC as Sephience sales priced in - MSN
PTC Therapeutics Shares Drop After RBC Downgrade - MarketScreener
PTC Therapeutics downgraded at RBC as Sephience sales priced in (PTCT:NASDAQ) - Seeking Alpha
Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors - The Manila Times
Cadrenal Therapeutics appoints PTC Therapeutics CMO to board - Investing.com
PTC Therapeutics stock downgraded by RBC Capital as shares near fair value - Investing.com Canada
RBC Downgrades PTC Therapeutics to Sector Perform From Outperform, Lifts Price Target to $91 From $82 - MarketScreener
(PTCT) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Elo Mutual Pension Insurance Co Makes New $689,000 Investment in PTC Therapeutics, Inc. $PTCT - MarketBeat
How The Sephience Launch Is Reshaping The Story For PTC Therapeutics’s Valuation - Yahoo Finance
A PTC Therapeutics (PTCT) Insider Sold 10,000 Shares for $795,000 - The Globe and Mail
Advantage Alpha Capital Partners LP Invests $204,000 in PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (PTCT) Stock on November 28, 2025: S&P SmallCap 600 Debut, Insider Selling and a 90% YTD Rally - ts2.tech
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to S&P 600 Health Care - MarketScreener
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to S&P Composite 1500 - MarketScreener
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to S&P 600 - MarketScreener
PTC Therapeutics, Inc.(NasdaqGS: PTCT) added to S&P 1000 - MarketScreener
PTC Therapeutics (NASDAQ:PTCT) Insider Sells $6,001,672.32 in Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Director Allan Steven Jacobson Sells 11,801 Shares - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 35,572 Shares of Stock - MarketBeat
PTC Therapeutics, Inc. (NASDAQ:PTCT) Held Back By Insufficient Growth Even After Shares Climb 29% - 富途牛牛
PTC Therapeutics exec Almstead sells $6m in shares By Investing.com - Investing.com South Africa
Why hedge funds are buying PTC Therapeutics Inc. stockMarket Movers & Verified Technical Trade Signals - moha.gov.vn
37,734 Shares in PTC Therapeutics, Inc. $PTCT Bought by Segall Bryant & Hamill LLC - MarketBeat
Insider Sell: Allan Jacobson Sells 26,000 Shares of PTC Therapeu - GuruFocus
PTC Therapeutics (NASDAQ:PTCT) Director Emma Reeve Sells 10,000 Shares - MarketBeat
PTC Therapeutics exec Almstead sells $6m in shares - Investing.com
PTC Therapeutics Executives Engage in Significant Stock Transactions - TradingView
Officer Almstead Sells 35,572 ($2.9M) Of PTC Therapeutics Inc [PTCT] - TradingView
Dir Jacobson Sells 26,000 ($2.1M) Of PTC Therapeutics Inc [PTCT] - TradingView
[Form 4] PTC THERAPEUTICS, INC. Insider Trading Activity - Stock Titan
Why PTC Therapeutics Inc. stock is favored by pension fundsInsider Selling & High Conviction Investment Ideas - BỘ NỘI VỤ
PTC Therapeutics (NASDAQ:PTCT) Shares Gap UpTime to Buy? - MarketBeat
0.66%
2.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):